Haidian, Beijing, China | Fund Name | Location |
| Antenna Group | California, San Francisco, United States |
| Basil Partners | Central Region, Singapore, Singapore |
| Bodhtree Consulting Ltd | California, Santa Clara, United States |
| Bridge Investments | - |
| Chengdu Venture Capital | Chengdu, China, Sichuan |
| Cleveland Clinic Innovations | Cleveland, Ohio, United States |
| Daxin Chuangtou | China, Guangdong Province, Panyu District |
| ETFS Capital | England, London, United Kingdom |
| Executive Forum Angels | New York, New York, United States |
| Nanjing Qingfang Touzi | China, Jiangsu, Nanjing |
| OCCIDENT | Switzerland, Zug, Zug |
| RACSeedSpark | - |
| Space Florida | Florida, Merritt Island, United States |
| Tech Capital Partners | Canada, Ontario, Waterloo |
| ThedaCare | Appleton, United States, Wisconsin |
| Undercurrent | New York, New York, United States |
| Viking Venture Management | Norway, Sor-Trondelag, Trondheim |
| VU Venture Partners | California, San Francisco, United States |
| Z5 Capital | California, Palo Alto, United States |
| Zijinhui | Beijing, China, Haidian |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
rivamed | $1M | 04 Jan 2018 | Beijing |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
rivamed | $1M | 04 Jan 2018 | Beijing |
